Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acacia Research (ACTG) EBT (2017 - 2025)

Acacia Research has reported EBT over the past 9 years, most recently at $6.0 million for Q4 2025.

  • Quarterly results put EBT at $6.0 million for Q4 2025, up 140.23% from a year ago — trailing twelve months through Dec 2025 was $31.3 million (up 182.08% YoY), and the annual figure for FY2025 was $31.3 million, up 182.08%.
  • EBT for Q4 2025 was $6.0 million at Acacia Research, up from -$3.4 million in the prior quarter.
  • Over the last five years, EBT for ACTG hit a ceiling of $228.3 million in Q4 2021 and a floor of -$163.6 million in Q1 2021.
  • Median EBT over the past 5 years was -$1.1 million (2024), compared with a mean of $5.4 million.
  • Biggest five-year swings in EBT: tumbled 1195.07% in 2021 and later skyrocketed 2381.12% in 2025.
  • Acacia Research's EBT stood at $228.3 million in 2021, then tumbled by 108.93% to -$20.4 million in 2022, then skyrocketed by 459.74% to $73.4 million in 2023, then crashed by 120.17% to -$14.8 million in 2024, then skyrocketed by 140.23% to $6.0 million in 2025.
  • The last three reported values for EBT were $6.0 million (Q4 2025), -$3.4 million (Q3 2025), and -$890000.0 (Q2 2025) per Business Quant data.